EFDID: 39926EFD: View Filing

Issuer: FLUOROPHARMA MEDICAL, INC. (0001402785) - D

Accession: 0001140361-11-036123 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001402785
  • Entity Name:
    FLUOROPHARMA MEDICAL, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEVADA
  • Year of Inc:
    Within 5 years (2007)
  • Address:
    500 Boylston Street
    Suite 1600
    Boston, MA 02116
  • Persons:
    Related Persons 4
    Johan (Thijs) M. Spoor
    Executive OfficerDirector
    David R. Elmaleh
    Executive OfficerDirector
    Walter Witshkin
    Director
    Peter S. Conti
    Director
EDGAR: Offering Information
  • Accession Date:
    07/07/2011
  • First Sale Date:
    06/23/2011
  • Offering Amount:
    $6,000,000
  • Amount Sold:
    $2,355,621
  • Amount Remaining:
    $3,644,379
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Noble Financial Capital Markets 15768 None 15768 FL, IL, NJ, NV, NY
Monarch Capital Group, LLC 47815 None 47815 CT, MD, MN, NJ, NY, PA, VA
Burnham Hill Partners, LLC 148000 None 148000 MA, NJ, NY, UT
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
FLUOROPHARMA MEDICAL, INC./s/ Johan M. (Thijs) SpoorJohan M. (Thijs) SpoorChief Executive Officer2011-07-07